Less than 15 months ago, Rampart Bioscience launched with $125 million to solve one of the toughest problems in genetic medicine: figuring out how to deliver genes into cells without a virus …
Read More from Endpoints News
Secretive Rampart Bioscience closes after pursuing non-viral gene therapy
